CClinicalTrials.gg
CompletedNCT02483741Updated Dec 7, 2016

The Use of Manuka Honey to Improve Healing After Third Molars Surgery

An interventional study of Manuka Honey in Surgical Extraction of Impacted Third Molars, sponsored by Damascus University. Completed at 1 site in Syrian Arab Republic. Open to participants aged 20 Years to 37 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-12-07.

Sponsored by Damascus University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years to 37 Years
Sex
All
01

Study summary

Since there is an evidence that Manuka honey is an antibacterial agent, the present study aims to confirm this characteristic and assess its effect in improving healing and reducing postsurgical symptoms, if topically applied after the surgical removal of impacted mandibular third molars

Read the detailed description

Sufficient evidence exists recommending the use of honey in the management of acute wounds and burns. Studies revealed that the healing effect of honey could be classified by its antibacterial, antiviral, anti-inflammatory and antioxidant properties of its components. Manuka honey has been shown to inhibit a wide range of microorganisms, including multiresistant strains. This unique honey is derived from flowers of manuka tree (Leptospermum scoparium) in New Zealand. Dihydroxyacetone and methylglyoxal are unique and naturally occurring constituents of manuka honey that correlate with its antibacterial activity.

Since surgical extraction of impacted molars is one of the most common operations in the oral cavity and the postoperative symptoms disturbing the patient may reduce the quality of health service, this study aims to assess the healing potential of Manuka honey in reducing these symptoms by comparing the outcome of extraction of impacted lower molars with and without topical application of Manuka honey into the extraction socket.

02

Conditions studied

  • Surgical Extraction of Impacted Third Molars

Browse trials for

03

In context

Tooth, Impacted

195 studies on the registry are indexed under Tooth, Impacted; 20 are open to participants now.

This study's enrollment of 50 is close to the median of 53 across 164 interventional studies indexed under Tooth, Impacted.

Browse Tooth, Impacted studies →

Lead sponsor

Damascus University is the lead sponsor of 206 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 37 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Asymptomatic, Symmetrical, Bilateral Impacted Third Molars

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled diabetes,
  • Hypersensitivity to Honey
  • Alcoholism,
  • Drug abuse,
  • Pathological condition in the region
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Manuka Honey

    Manuka Honey will be placed in the sockets of the extracted third molars in this group

    Biological: Manuka Honey

  • No intervention
    Traditional Extraction

    No any special material will be placed in the sockets of the extracted third molars in this group

Interventions

  • BiologicalManuka Honey

    This material is going to be placed into the sockets of the extracted third molars in the experimental group

06

What researchers measure

Primary outcomes

  1. Levels of postoperative discomfort

    Postoperative Symptom Severity (PoSSe) Scale will be used for this variable. The patient will be asked to fill in a questionnaire on the 7th day following surgery. This questionnaire is used to assess postoperative discomfort in patients who have third molars extracted. PoSSe Scale consists of 7 sub-scales that investigate the patient's ability to enjoy food; speak properly; perceive altered sensations, appearance, pain, and sickness; and interference with daily activities.

    Time frame: 7 days after the surgical removal of third molars

  2. Change of facial contours due to swelling

    In order to assess facial swelling, the distances between the labial commissure and the tragus, and between the lateral canthus and the gonion will be measured. The change between 3 days and before surgery will give an idea about the amount of swelling that occurred following surgery. Between 3 days and 7 days will give an idea about the change that occurred in this period.

    Time frame: Measurements will be taken before surgery, on the 3rd and on the 7th days after surgery.

  3. Change of the masticatory muscles status

    Mouth opening range will be assessed by measuring the distance between the upper and lower incisors using a vernier caliper when the patient is asked to open his/her mouth as much as possible. The presence of limited opening of the mouth is an indication of trismus.

    Time frame: Measurements will be taken before surgery, on the 3rd and on the 7th days after surgery.

  4. Pain and Change of pain

    using a Visual Analog Scale of Faces (VASoF).

    Time frame: This will be assessed on the 3rd and 7th day following surgery

  5. The presence or absence of alveolar osteitis

    The presence of a dry socket condition will be checked out at two time points.

    Time frame: This will be assessed on the 3rd and 7th day following surgery

Secondary outcomes

  1. Time required to hemostasis

    Time frame: This will be recorded by the patient in the immediate postsurgical phase (i.e. between 10 minutes up to 72 hours following surgery)

  2. Bone density and quality

    This will be assessed using Cone-beam computed tomography (CBCT) images. Hounsfield Units will be used to quantify bone density and quality.

    Time frame: at six months following surgery

  3. Change of bone healing status

    This will be assessed using panoramic radiographs

    Time frame: at 3 and six months following surgery

07

Study locations

1 site
  • Department of Oral and Maxillofacial Surgery, University of Damascus Dental School
    Damascus, Damscus DM20AM18, Syrian Arab Republic
08

References and documents

Publications

  • Atrott J, Haberlau S, Henle T. Studies on the formation of methylglyoxal from dihydroxyacetone in Manuka (Leptospermum scoparium) honey. Carbohydr Res. 2012 Nov 1;361:7-11. doi: 10.1016/j.carres.2012.07.025. Epub 2012 Aug 8. PubMed 22960208 ↗
  • Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res. 2008 Apr;52(4):483-9. doi: 10.1002/mnfr.200700282. PubMed 18210383 ↗
  • Rathnam A, Madan N, Madan N. The language of pain: A short study. Contemp Clin Dent. 2010 Jul;1(3):142-5. doi: 10.4103/0976-237X.72778. PubMed 22114404 ↗
  • Ruta DA, Bissias E, Ogston S, Ogden GR. Assessing health outcomes after extraction of third molars: the postoperative symptom severity (PoSSe) scale. Br J Oral Maxillofac Surg. 2000 Oct;38(5):480-7. doi: 10.1054/bjom.2000.0339. PubMed 11010778 ↗
  • Singh V, Pal US, Singh R, Soni N. Honey a sweet approach to alveolar osteitis: A study. Natl J Maxillofac Surg. 2014 Jan;5(1):31-4. doi: 10.4103/0975-5950.140166. PubMed 25298714 ↗
  • Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J. 2009 May 22;122(1295):47-60. PubMed 19648986 ↗
  • Yaghoobi R, Kazerouni A, Kazerouni O. Evidence for Clinical Use of Honey in Wound Healing as an Anti-bacterial, Anti-inflammatory Anti-oxidant and Anti-viral Agent: A Review. Jundishapur J Nat Pharm Prod. 2013 Aug;8(3):100-4. doi: 10.17795/jjnpp-9487. Epub 2013 Jul 17. PubMed 24624197 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02483741
Lead sponsor
Damascus University
Responsible party
Sponsor
First posted
Jun 29, 2015
Start date
Jun 2015
Primary completion
May 2016
Completion
Nov 2016
Last update
Dec 7, 2016

Study contacts

Nuraldeen Al-Khanati, DDS
principal investigator · MSc student, Oral and Maxillofacial Department, University of Damascus Dental School
Yasser Al-Moudallal, DDS MSc PhD
study director · Associate Professor of Oral and Maxillofacial Surgery, University of Damascus Dental School

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion